Stephane Navé

545 total citations
11 papers, 252 citations indexed

About

Stephane Navé is a scholar working on Physiology, Pharmacology and Surgery. According to data from OpenAlex, Stephane Navé has authored 11 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Pharmacology and 2 papers in Surgery. Recurrent topics in Stephane Navé's work include Alzheimer's disease research and treatments (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Nausea and vomiting management (2 papers). Stephane Navé is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Nausea and vomiting management (2 papers). Stephane Navé collaborates with scholars based in Switzerland, United States and France. Stephane Navé's co-authors include Wim J. Riedel, Anke Sambeth, Eric Vuurman, Will Spooren, Luca Santarelli, A.M.W. Linssen, Gabriel Vargas, Eric Prinssen, Bart Ellenbroek and Almas Siddiqui and has published in prestigious journals such as Blood, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Stephane Navé

11 papers receiving 247 citations

Peers

Countries citing papers authored by Stephane Navé

Since Specialization

Citations

This map shows the geographic impact of Stephane Navé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephane Navé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephane Navé more than expected).

Fields of papers citing papers by Stephane Navé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephane Navé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephane Navé. The network helps show where Stephane Navé may publish in the future.

Co-authorship network of co-authors of Stephane Navé

This figure shows the co-authorship network connecting the top 25 collaborators of Stephane Navé. A scholar is included among the top collaborators of Stephane Navé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephane Navé. Stephane Navé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man 2021 ·Scientific Reports ·Joerg F. Hipp, Frédéric Knoflach, Robert A. Comley, Theresa M. Ballard, Michael Honer, Gerhard Trube, Rodolfo Gasser, Eric Prinssen, Tanya L. Wallace, Andreas Rothfuß, Henner Knust, (unknown), Michael Derks, Darren Bentley, Lisa Squassante, Stephane Navé, (unknown), Christoph Wandel, Andrew W. Thomas, Maria‐Clemencia Hernandez	24
2	Phase 2 Clinical Trial Results for Bitopertin, an Oral Glycine Transporter 1 Inhibitor, in Patients with Non-Transfusion Dependent Beta-Thalassemia 2018 ·Blood ·Alì Taher, Vip Viprakasit, Maria Domenica Cappellini, Dominik Kraus, Patrick G. Cech, (unknown), (unknown), Norman A. Mazer, Stephane Navé, Juergen Dukart, (unknown), (unknown), Omar Khwaja, Ricardo Hermosilla	3
3	Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Edilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Navé, Hansruedi Loetscher, Shankar J. Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, (unknown), Axel Pähler, Julie K. Andersen, R. Wyler, Andrea M. Cesura	75
4	Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Anton Forsberg, Stephane Navé, Per Stenkrona, Nicholas Seneca, Andrea Varrone, Robert A. Comley, Patrik Fazio, Candice Jamois, Ryuji Nakao, (unknown), Nabil Al‐Tawil, (unknown), Christer Halldin, Niels Andreasen, Benedicte Ricci	21
5	P4–312: Preclinical characterization of RO4602522, a novel, selective and orally active monoamine oxidase type B inhibitor for the treatment of Alzheimer's disease 2013 ·Alzheimer s & Dementia ·Edilio Borroni, R. Wyler, (unknown), Stephane Navé, Andrea M. Cesura	4
6	P3–300: Brain MAO‐B inhibition in healthy elderly and people with Alzheimer's disease after oral administration of RO4602522 2013 ·Alzheimer s & Dementia ·Benedicte Ricci, (unknown), Nicholas Seneca, Candice Jamois, Stephane Navé, (unknown), (unknown), (unknown), Anton Forsberg, Patrik Fazio, Christer Halldin, Nabil Al‐Tawil, (unknown), Niels Andreasen	2
7	Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate 2011 ·Psychopharmacology ·A.M.W. Linssen, Eric Vuurman, Anke Sambeth, Stephane Navé, Will Spooren, Gabriel Vargas, Luca Santarelli, Wim J. Riedel	58
8	Single Ascending Dose Tolerability, Pharmacokinetic–Pharmacodynamic Study of Dihydropyrimidine Dehydrogenase Inhibitor Ro 09-4889 2004 ·Clinical Cancer Research ·S. Eralp Bellibas, (unknown), Emmanuel Chamorey, (unknown), (unknown), (unknown), Stephane Navé, Ludger Banken, N. Renée, G. Milano	4
9	The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects 1999 ·British Journal of Clinical Pharmacology ·Cornelia Weber, Ludger Banken, Herbert Birnboeck, Stephane Navé, Rainer Schulz	24
10	Oral Dolasetron Mesylate for Prevention of Postoperative Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Study 1998 ·Journal of Clinical Anesthesia ·(unknown), Kari Korttila, (unknown), J. H. J. H. Helmers, (unknown), Stephane Navé, (unknown), William F. Hahne, (unknown)	19
11	Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery 1997 ·Journal of Clinical Anesthesia ·Pierre Diemunsch, Alain D’Hollander, (unknown), P. Schoeffler, (unknown), Stephane Navé, Robert A. Brown, William F. Hahne	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact